GARDEN CITY, N.Y. — January 27, 2026 — Leads & Copy — Beyond Air, Inc. (NASDAQ: XAIR) announced that Chairman & Chief Executive Officer Steve Lisi will participate in two upcoming conferences.
Lisi will attend the 13th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, scheduled for February 9th to 11th in Snowbird, UT. The conference will feature one-on-one meetings.
Additionally, Lisi will participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference. He is scheduled to deliver a corporate presentation and hold one-on-one meetings. The presentation is scheduled for Thursday, February 5th at 2:00pm ET.
Those interested in viewing the live presentation can register for the event at no cost through the Virtual Equity Conference Registration link. An archive of the webcast will be available for 90 days following the event at https://www.beyondair.net/news-events/events.
Individuals interested in requesting a one-on-one meeting at either conference can contact their respective bank representative to schedule.
Beyond Air is a commercial-stage medical device and biopharmaceutical company focused on using nitric oxide to improve the lives of patients. The company has received FDA approval and CE Mark for its LungFit PH system, used for treating term and near-term neonates with hypoxic respiratory failure. Beyond Air is currently conducting clinical trials of its LungFit systems for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria (NTM).
Beyond Cancer, Ltd., an affiliate of Beyond Air, is investigating ultra-high concentrations of NO with a delivery system to target certain solid tumors in the pre-clinical setting.
Source: Beyond Air
